on a mobile?
vTap
    Loading...
 
 
Video
61
Generic drug giant Teva Pharmaceuticals bought rival Barr for $7 billion, and some analysts say this could spark a big wave of consolidation. CNBC's Mike Huckman has the details.
4 months ago
MSN Video
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Generic drug
Teva Pharmaceutical Industries
Go to Feed to see what's new!
share
keep
 
 
A look at the consolidation trends in the generic drug sector, with Shlomo Yanai, Teva Pharmaceuticals CEO
4 months ago
MSN Video
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Generic drug
Teva Pharmaceutical Industries
Go to Feed to see what's new!
share
keep
 
 
Shlomo Yanai, chief executive officer of Teva Pharmaceutical Industries Ltd., and Bruce Downey, chief executive officer of Barr Pharmaceuticals Inc., talk with Bloomberg's Deirdre Bolton in New York ...
4 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Barr Pharmaceuticals
Bruce Downey
Teva Pharmaceutical Industries
New York
Chief executive officer
Go to Feed to see what's new!
share
keep
 
 
805
Joint Interview with Teva CEO Shlomo Yanai and Barr CEO Bruce Downey
4m 56s |
4 months ago
YouTube
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Bruce Downey
Inside Look (tvseries)
Bloomberg (YouTube)
Go to Feed to see what's new!
share
my users
keep
 
 
49
Joint Interview with Teva CEO Shlomo Yanai and Barr CEO Bruce Downey
4m 32s |
4 months ago
YouTube
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Bruce Downey
Inside Look (tvseries)
Bloomberg (YouTube)
Go to Feed to see what's new!
share
my users
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Corey Davis, an analyst at Natixis Bleichroeder, talks with Bloomberg's Carol Massar and Julie Hyman in New York about Teva Pharmaceutical Industries Ltd.'s plan to buy Barr Pharmaceuticals Inc. Teva, the world's biggest maker of generic drugs agreed to buy rival Barr for $7.46 billion to expand into new markets and widen its lead in copying brand-name medicines. (Source: Bloomberg)
4 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Barr Pharmaceuticals
Teva Pharmaceutical Industries
Generic drug
New York
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use